| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/12/2015 | WO2015019246A1 Reducing reflux while sleeping by stimulating saliva with adhering troches |
| 02/12/2015 | WO2015019237A1 Pharmaceutical composition of vilazodone |
| 02/12/2015 | WO2015019230A1 Bag3 receptor binding molecules for use as a medicament |
| 02/12/2015 | WO2015019124A1 Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids |
| 02/12/2015 | WO2015019121A1 Styryl quinazoline derivatives as pharmaceutically active agents |
| 02/12/2015 | WO2015019103A1 Piperidine and azepine derivatives as prokineticin receptor modulators |
| 02/12/2015 | WO2015019037A1 Pharmaceutical compounds |
| 02/12/2015 | WO2015019030A1 Novel combination of 6-({7-[(1-aminocyclopropyl)methoxy]-6-methoxyquinolin-4-yl}oxy)-n-methylnaphthalene-1-carboxamide and an anti-oestrogen in breast cancer |
| 02/12/2015 | WO2015018913A1 Ketone body and ketone body ester for reducing muscle breakdown |
| 02/12/2015 | WO2015018858A1 Compositions comprising vitamin k derivatives and salts |
| 02/12/2015 | WO2015018831A1 Ligase e3 rnf185 inhibitors and uses thereof |
| 02/12/2015 | WO2015018823A1 Thieno[2,3-c]pyrans as cftr modulators |
| 02/12/2015 | WO2015018814A1 Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof |
| 02/12/2015 | WO2015018808A1 Substituted imidazo[1,2-a]pyrazinecarboxamides and use thereof |
| 02/12/2015 | WO2015018800A1 Inhalable particles comprising tiotropium and indacaterol |
| 02/12/2015 | WO2015018797A2 Antiviral compounds |
| 02/12/2015 | WO2015018794A1 A pharmaceutical composition containing ropinirole hcl administrable by oral route, and manufacturing method thereof |
| 02/12/2015 | WO2015018757A1 25-oh vitamin d derivatives for determination of vitamin d metabolites |
| 02/12/2015 | WO2015018754A1 Novel pyrazine amide compounds |
| 02/12/2015 | WO2015018698A1 Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids |
| 02/12/2015 | WO2015018660A1 Carnitine palmitoyltransferase 1 inhibitors for inhibition of pathological angiogenesis |
| 02/12/2015 | WO2015018523A1 A novel bet-brd inhibitor for treatment of solid tumors |
| 02/12/2015 | WO2015018522A1 Bet-bromodomain inhibitor shows synergism with several anti-cancer agents in pre-clinical models of diffuse large b-cell lymphoma (dlbcl) |
| 02/12/2015 | WO2015018521A1 Method of treating diffuse large b-cell lymphoma (dlbcl) using a bet-bromodomain inhibitor |
| 02/12/2015 | WO2015018520A1 A bet-brd inhibitor represents a novel agent for alk positive anaplastic large cell lymphoma |
| 02/12/2015 | WO2015018475A1 Piperidine urea derivatives |
| 02/12/2015 | WO2015018461A1 Therapeutic compositions comprising hyaluronic acid |
| 02/12/2015 | WO2015018356A1 Diarylhydantoin derivative, and preparation method, pharmaceutical composition, and application thereof |
| 02/12/2015 | WO2015018344A1 Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereof |
| 02/12/2015 | WO2015018343A1 Medicine composition for wound therapy |
| 02/12/2015 | WO2015018333A1 Inhibitors of bruton's tyrosine kinase |
| 02/12/2015 | WO2015018182A1 Phenylacetic acid derivative and antitumor use thereof |
| 02/12/2015 | WO2015018176A1 Specific fluorescent probe of glucuronosyltransferase ugt1a1 and use thereof |
| 02/12/2015 | WO2015018128A1 Hypoglycemic chinese medicine preparation and preparation method therefor |
| 02/12/2015 | WO2015018127A1 Hypolipidemic chinese medicine preparation and preparation method therefor |
| 02/12/2015 | WO2015018029A1 Oxazole orexin receptor antagonists |
| 02/12/2015 | WO2015018027A1 Thiazole orexin receptor antagonists |
| 02/12/2015 | WO2015017934A1 Improvement of blood lipids, glucose tolerance and insulin sensitivity |
| 02/12/2015 | WO2015017915A1 Methods of treating taxane naïve subjects with primary tumors or with metastatic cancer |
| 02/12/2015 | WO2015017906A1 Diphenyloxyalkylamine derivatives and aryloxyalkylamine derivatives, pharmaceutical composition, use of said pharmaceutical composition for treating, preventing or inhibiting chronic pulmonary inflammatory diseases and method for treating or preventing such diseases |
| 02/12/2015 | WO2015017901A1 Wheat having high levels of beta-glucan |
| 02/12/2015 | US20150047064 INHIBITING GENE EXPRESSION WITH dsRNA |
| 02/12/2015 | US20150047059 Activity modulator, medicinal agent comprising same, use of cd300a gene-deficient mouse, and anti-cd300a antibody |
| 02/12/2015 | US20150045764 Silk reservoirs for drug delivery |
| 02/12/2015 | US20150045749 Percutaneous absorption preparation containing donepezil, and method for preparing same |
| 02/12/2015 | US20150045748 Transdermal device including porous microparticles |
| 02/12/2015 | US20150045739 Method for treating otic infections after tympanostomy tube placement |
| 02/12/2015 | US20150045719 Combination of a mc1r receptor agonist and uvb for the treatment and/or prevention of pigmentation disorders |
| 02/12/2015 | US20150045610 Method of modifying spermatogenesis, spermiogenesis and/or fertility in mammals |
| 02/12/2015 | US20150045555 Conjugate of Polyethylene Gylcol and Naloxone and Pharmaceutical Composition and Use Thereof |
| 02/12/2015 | US20150045552 5ht2c receptor modulators |
| 02/12/2015 | US20150045448 Amantadine compositions and methods of use |
| 02/12/2015 | US20150045447 Amantadine compositions and methods of use |
| 02/12/2015 | US20150045446 Amantadine compositions and methods of use |
| 02/12/2015 | US20150045445 3-keto-n-propargyl-1-aminoindan |
| 02/12/2015 | US20150045441 Crystalline Diacylhydrazine and the Use Thereof |
| 02/12/2015 | US20150045440 Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid |
| 02/12/2015 | US20150045439 Amantadine compositions and methods of use |
| 02/12/2015 | US20150045438 Amantadine compositions and methods of use |
| 02/12/2015 | US20150045437 Transdermal delivery kits |
| 02/12/2015 | US20150045433 Methods and compositions for inducing physiological hypertrophy |
| 02/12/2015 | US20150045432 Dietary supplement comprising amino acids in a palatable liquid formulation that promotes restful sleep, recovery from stress and exercise and strengthens the immune system |
| 02/12/2015 | US20150045431 Methods of treating a cardiovascular disorder in a subject on apo-c3 modulating therapy |
| 02/12/2015 | US20150045425 Peltatin and metabolic disorders |
| 02/12/2015 | US20150045424 Composition useful for the treatment of type 2 diabetes |
| 02/12/2015 | US20150045422 Influenza treatment using targeted transient ribosomal inhibition |
| 02/12/2015 | US20150045419 Reversibly crosslinked micelle systems |
| 02/12/2015 | US20150045418 Methods and materials for treating cancer |
| 02/12/2015 | US20150045416 Methods and Compositions for Gene Delivery |
| 02/12/2015 | US20150045410 Method of regulating cftr expression and processing |
| 02/12/2015 | US20150045407 Mtk1-actin inhibitors and methods of use |
| 02/12/2015 | US20150045406 Curaxins for use in treating breast cancer and method for identifing patients likely to respond |
| 02/12/2015 | US20150045405 CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride |
| 02/12/2015 | US20150045403 Pharmaceutical Cream Compositions and Methods of Use |
| 02/12/2015 | US20150045401 Prodrugs of riluzole and their method of use |
| 02/12/2015 | US20150045400 Ritonavir compositions |
| 02/12/2015 | US20150045398 ArylSulfonamide-Based Matrix Metalloprotease Inhibitors |
| 02/12/2015 | US20150045396 Prophylactic or therapeutic agent for giant cell tumors occurring in bone and soft tissue or for chondrosarcoma |
| 02/12/2015 | US20150045392 Methods of treating pruritic conditions mediated through histamine h-4 receptors |
| 02/12/2015 | US20150045391 Filanesib combined with pomalidomide displays enhanced anti-tumor activity |
| 02/12/2015 | US20150045390 Iloperidone metabolite for use in the treatment of psychiatric disorders |
| 02/12/2015 | US20150045388 Topical regional neuro-affective therapy |
| 02/12/2015 | US20150045385 Brain function improving agent |
| 02/12/2015 | US20150045383 Treating pain in patients with hepatic impairment |
| 02/12/2015 | US20150045382 Rifaximin complexes |
| 02/12/2015 | US20150045381 Compositions and methods for sustained energy and enhanced weight loss |
| 02/12/2015 | US20150045380 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 02/12/2015 | US20150045375 Novel compounds |
| 02/12/2015 | US20150045374 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids |
| 02/12/2015 | US20150045366 Spray dried formulations |
| 02/12/2015 | US20150045364 Pyridine and Pyrazine derivative for the Treatment of CF |
| 02/12/2015 | US20150045363 Hedgehog Pathway Inhibition for Cartilage Tumor and Metachondromatosis Treatment |
| 02/12/2015 | US20150045358 Pharmaceutical composition for treating disorders associated with insulin resistance |
| 02/12/2015 | US20150045357 Small molecule inhibitors of mcl-1 and uses thereof |
| 02/12/2015 | US20150045354 Anti-Malarial Agents |
| 02/12/2015 | US20150045353 Formulations containing gamma secretase modulators, methods for preparation and delivery thereof |
| 02/12/2015 | US20150045352 COMPOSITIONS CONTROLLING pH RANGE OF RELEASE AND/OR RELEASE RATE |
| 02/12/2015 | US20150045350 Method for noribogaine treatment in patients on methadone |
| 02/12/2015 | US20150045345 Solid pharmaceutical composition containing 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof |
| 02/12/2015 | US20150045344 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof |